Heterocyclic Compounds with Heteroatom
Código 2933 (Harmonized System 2012 by 4 digits)
2024: US$576M, Total Trade Exchange
2024: US$116M, International Sales
2024: US$460M, International Purchases
Código 2933 (Harmonized System 2012 by 4 digits)
2024: US$576M, Total Trade Exchange
2024: US$116M, International Sales
2024: US$460M, International Purchases
In 2024, the trade exchange (includes international purchases and sales) of Heterocyclic Compounds with Heteroatom was US$576M.
In 2024, the states with the most international sales in Heterocyclic Compounds with Heteroatom were Estado de México (US$73.2M), Nuevo León (US$16.3M), Morelos (US$9.57M), Ciudad de México (US$9.24M), and Jalisco (US$2M).
The states with the most international purchases in 2024 were Ciudad de México (US$191M), Jalisco (US$115M), Estado de México (US$84.8M), Nuevo León (US$17.7M), and Tamaulipas (US$8.14M).
In 2024, the main commercial destinations of Heterocyclic Compounds with Heteroatom were Canada (US$41.3M), India (US$20.1M), United States (US$16.3M), Brazil (US$12.4M), and Belgium (US$3.96M).
The main commercial origins of Heterocyclic Compounds with Heteroatom in 2024 were China (US$188M), India (US$111M), Germany (US$29.3M), United States (US$29M), and Brazil (US$14.9M).
In the global context, the main exporting countries of Heterocyclic Compounds with Heteroatom in 2022 were China (US$23.2B), Ireland (US$22.3B), and Switzerland (US$15B). In the same year, the main importing countries of Heterocyclic Compounds with Heteroatom were Germany (US$19.7B), United States (US$14.9B), and Ireland (US$11.2B).
US$576M, Total Trade Exchange (2024)
In 2024, the total trade exchange of Heterocyclic Compounds with Heteroatom in Mexico (including international purchases and sales) was US$576M.
The visualizations show the net balance of Heterocyclic Compounds with Heteroatom at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
March, 2025
In March 2025, international sales of Heterocyclic Compounds with Heteroatom were US$9.64M, while international purchases reached US$34.9M. The above results in a trade balance of -US$25.2M.
2025-Q1: US$21.6M, International Sales
The visualization shows the quarterly concentration of international sales of Heterocyclic Compounds with Heteroatom at state level.
In the first quarter of 2025, international sales were US$21.6M, being the states with the most sales Estado de México (US$11.6M), Nuevo León (US$6.72M), and Ciudad de México (US$1.63M).
Estado de México: US$73.2M, State with the Most International Sales (2024)
Canada: US$41.3M, Main commercial destination (2024)
In 2024, the states with the highest international sales in Heterocyclic Compounds with Heteroatom were Estado de México (US$73.2M), Nuevo León (US$16.3M), Morelos (US$9.57M), Ciudad de México (US$9.24M), and Jalisco (US$2M).
In 2024, the countries with the most international purchases from Mexico were Canada (US$41.3M), India (US$20.1M), United States (US$16.3M), Brazil (US$12.4M), and Belgium (US$3.96M).
Ciudad de México: US$191M, State with the Most International Purchases (2024)
China: US$188M, Main Commercial Origin (2024)
In 2024, the states with the highest international in Heterocyclic Compounds with Heteroatom were Ciudad de México (US$191M), Jalisco (US$115M), Estado de México (US$84.8M), Nuevo León (US$17.7M), and Tamaulipas (US$8.14M).
The countries with the most international sales to Mexico in 2024 were China (US$188M), India (US$111M), Germany (US$29.3M), United States (US$29M), and Brazil (US$14.9M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Heterocyclic Compounds with Heteroatom and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Heterocyclic Compounds with Heteroatom. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Heterocyclic Compounds with Heteroatom. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Heterocyclic Compounds with Heteroatom were China (US$23.2B), Ireland (US$22.3B), and Switzerland (US$15B). In the same year, the main importing countries for Heterocyclic Compounds with Heteroatom were Germany (US$19.7B), United States (US$14.9B), and Ireland (US$11.2B).